Andrew Livingston

Chief Executive Officer at Exactmer

Speaker

Prof Andrew Livingston (CEO & Co-Founder) has 30+ years of expertise in chemical engineering, biotech and commercialisation of new technologies. He was the Founder and CEO of Membrane Extraction Technology Ltd, which was acquired by Evonik AG at a significant share price multiple for investors in 2010. As CEO, he developed business plans, raised finance; and was responsible for all operational matters. He has acted as a consultant to clients including GSK, Pfizer, Exxon, Shell, BP and Unilever and regularly carries out due diligence work for investors on the technical prospects of new chemical science based technologies. In December 2017, with Piers Gaffney, he founded Exactmer for commercialisation of high value therapeutic polymers using the Nanostar Sieving technology, developed through his academic research group, LivingstonLab. His research expertise is in creating molecular separation membranes and deploying them to invent new chemical processes.

Prof Livingston holds a PhD in chemical engineering from Trinity College, University of Cambridge, an MSc in Economics from London School of Economics (LSE), and Chartered Engineer status. His previous roles include Head of the Chemical Engineering Department at Imperial College London (2008-2016) and academic lead then interim Director of the Rosalind Franklin Institute (2017- 2019). Since November 2019 he has been the Vice-Principal (Research and Innovation) at Queen Mary University of London (QMUL). In these roles he has been responsible for both strategy and operations, and accountable for KPIs including financial performance. He has received numerous awards, and was elected a Fellow of the Royal Academy of Engineering in 2006 and a Fellow of the Royal Society in 2022.